MedTrace Logo

Characterization of Gut Microbiota in Chronic Liver Disease With Decreased Muscle Mass

NCT05729269 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 283

Last updated 2023-02-15

No results posted yet for this study

Summary

The purpose of this study was to confirm the presence of specific gut microbiota observed in patients with sarcopenia among patients who agreed to analyze gut microbiota through stool among multi-center chronic liver disease cohort patients.

Conditions

  • Gastrointestinal Microbiome
  • Sarcopenia
  • Liver Disease Chronic

Interventions

DIAGNOSTIC_TEST

Sarcopenia_CT

measurement of skeletal muscle through abdominal computed tomography

Sponsors & Collaborators

  • Dongtan Sacred Heart Hospital

    collaborator OTHER

  • Hallym University Medical Center

    collaborator OTHER

  • Hangang Sacred Heart Hospital

    collaborator OTHER

  • Kangdong Sacred Heart Hospital

    collaborator OTHER

  • Yonsei University

    collaborator OTHER

  • Chuncheon Sacred Heart Hospital

    lead OTHER

Eligibility

Min Age
24 Years
Max Age
82 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-22
Primary Completion
2019-04-30
Completion
2021-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05729269 on ClinicalTrials.gov